New drug KH815 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called KH815 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of advanced solid tumor that standard treatments no longer work for or are not suitable.
- You are between 18 and 75 years old.
- You have not had certain cancer treatments within the past few weeks (chemotherapy, radiation, major surgery, or other drugs).
- Your tumors can be measured on a CT or MRI scan.
- You are generally active and able to take care of yourself (ECOG score of 0 or 1).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called KH801 for people with advanced solid tumors (cancers that have spread) that haven't been helped by other treatments. The goal is to see if it is safe and how well it works.
This Phase 1 trial tests KH617, a new treatment, in adults with advanced cancers to see if it can be given safely and whether it shows signs of benefit. It is especially focused on tumors that have few or no standard treatment options, including certain brain tumor recurrences.
This Phase 1 trial studies how a new medicine (KC1036) works and how safe it is for people with advanced solid cancers that have grown despite standard treatments. It may help future patients by showing whether the drug can control cancer in difficult-to-treat cases.
This trial tests a new drug called HSK39775 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and effective for people who have few other options.
This trial is testing an investigational drug called SHR-7787 for people with advanced solid tumors (cancer that has spread or can't be removed). The goal is to see if it is safe and how well it works. It may be an option if your tumor type is no longer responding to other treatments.
This is an early-stage trial testing a new drug called KHN922 in patients with advanced or hard-to-treat solid cancers. Researchers want to see if this drug is safe and if it can help slow or shrink tumors.
Hear when a new Advanced Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.